Tata Chemicals Limited reported results for the quarter and nine months ended 31 December 2025. Consolidated revenue was Rs 35.5 bn and EBITDA Rs three point four five bn, including an exceptional charge of Rs 540 mn for the new labour code. Net debt at 31 December was Rs 55.96 bn excluding leases of Rs 7.72 bn and profit before exceptional items and non-controlling interest showed a loss of Rs 150 mn. Standalone revenue was Rs 12.04 bn with EBITDA of Rs two point two eight bn. Management said soda ash markets remained oversupplied with high inventory and softened prices, leaving the near-term outlook subdued. Standalone performance benefited from higher volumes and cost discipline, and UK operations were reconfigured to focus on value-added non-cyclical products. The company announced the acquisition of Novabay Pte Limited to strengthen specialty chemicals presence, with completion expected in the fourth quarter of FY26 subject to customary conditions. The board approved Rs five point one five bn to build a greenfield iodised vacuum salt dried facility at Valinokkam, Ramanathapuram, Tamil Nadu, with capacity of 210,000 t per annum. The project will strengthen the consumer products portfolio and expand manufacturing in India. The company commissioned a pearl silica facility of 3,000 t per annum at Cuddalore and a FOS L55 unit of 4,500 t per annum at Mambattu. Company priorities are to protect margins, preserve cash flows and maintain balance sheet strength through disciplined capacity utilisation. For the nine months ended 31 December 2025 consolidated revenue was Rs 111.46 bn and EBITDA Rs 15.31 bn, while profit before exceptional items and non-controlling interest was Rs five point two bn. Standalone nine months revenue was Rs 35.77 bn with EBITDA of Rs seven point three eight bn and profit from continuing operations of Rs five point seven two bn. The company will continue to leverage global operations and research capabilities to pursue value-added growth.